Drug FDA Class II Ongoing Sub/super-potent
Isotretinoin Capsules, USP, 40 mg, 10 count Prescription Pacs, Rx only, Manufactured for: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0591-2436-15 (carton), NDC 0591-2436-45 (blister pack).
Teva Pharmaceuticals USA, Inc Published Apr 15, 2026
Risk level
Class IIMay cause a temporary or reversible health problem; slight chance of serious harm.
Severity score 50/100
What should you do?
- Check whether you have this product, using the lot codes, UPCs, and dates listed below.
- Do not eat, serve, or sell the affected product.
- Return it to the place of purchase for a refund, or throw it away in a sealed bag so people and animals can’t get to it.
- Contact Teva Pharmaceuticals USA, Inc or your place of purchase with questions, and see the source record below for full details.
Reason for recall
Superpotent and Subpotent
Hazards
Superpotency · primarySubpotency
Affected products (1)
Isotretinoin Capsules, USP, 40 mg, 10 count Prescription Pacs, Rx only, Manufactured for: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0591-2436-15 (carton), NDC 0591-2436-45 (blister pack).
ISOTRETINOIN · 8376 packages
NDC: 0591-2433, 0591-2434, 0591-2451, 0591-2435, 0591-2501, 0591-2436, 0591-2433-45, 0591-2433-15, 0591-2434-45, 0591-2434-15, 0591-2451-45, 0591-2451-15, 0591-2435-45, 0591-2435-15, 0591-2501-45, 0591-2501-15, 0591-2436-45, 0591-2436-15
Lot codes: 100075305
Code info: Lots 100075305 Exp date 06/2027, 100075512, Exp date 07/2027 & 100076103, Exp date 07/2027 .
Affected areas
FloridaMississippiOhioPuerto Rico
Timeline
- InitiatedJan 12, 2026
- PublishedApr 15, 2026
- Recall number
- D-0446-2026
- Agency
- U.S. Food and Drug Administration
- Country
- US
FDA records come from the openFDA drug enforcement-report dataset — the agency's full weekly enforcement list. Most entries are not issued as consumer press releases, so they won't appear on fda.gov/recalls or in a web search. The source record link above resolves this exact recall by its number.